Therapeutic Asset Ratings

149 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Abemaciclib Pancreatic Ductal Adenocarcinoma	University Health Network, Toronto	P2	CCC (51)
Certepetide Pancreatic Ductal Adenocarcinoma	Lisata Therapeutics, Inc.	P2	CCC (51)
FAPI74 Pancreatic Ductal Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (51)
Toripalimab Pancreatic Ductal Adenocarcinoma	Eucure (Beijing) Biopharma Co., Ltd	P2	CCC (51)
YH-003 (HUMANIZED AGONISTIC ANTI-CD40 IGG2 MONOCLONAL ANTIBODY) Pancreatic Ductal Adenocarcinoma	Eucure (Beijing) Biopharma Co., Ltd	P2	CCC (51)
Paricalcitol Pancreatic Ductal Adenocarcinoma	Fox Chase Cancer Center	P2	CCC (50)
Dc-Cik Pancreatic Ductal Adenocarcinoma	University of Malaya	P2/3	CCC (50)
GEH300079 (68Ga) Pancreatic Ductal Adenocarcinoma	GE Healthcare	P2/3	CCC (50)
Navlimetostat Pancreatic Ductal Adenocarcinoma	Bristol-Myers Squibb	P2/3	CCC (50)
ot-101 Pancreatic Ductal Adenocarcinoma	Oncotelic Inc.	P2/3	CCC (50)
TEGAFUR Pancreatic Ductal Adenocarcinoma	University of Malaya	P2/3	CCC (50)
Eli-002 7P Pancreatic Ductal Adenocarcinoma	Elicio Therapeutics	P1/2	CCC (49)
(+)-VINCRISTINE Pancreatic Ductal Adenocarcinoma	Pfizer	P1/2	CCC (49)
Adenovirus 5/F35-Human Guanylyl Cyclase C-Padre Pancreatic Ductal Adenocarcinoma	Thomas Jefferson University	P2	CCC (48)
azd0901 Pancreatic Ductal Adenocarcinoma	AstraZeneca	P2	CCC (48)
Cediranib Pancreatic Ductal Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (48)
Cipralex Pancreatic Ductal Adenocarcinoma	Case Comprehensive Cancer Center	P2	CCC (48)
DARATUMUMAB Pancreatic Ductal Adenocarcinoma	Georgetown University	P2	CCC (48)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4) Pancreatic Ductal Adenocarcinoma	University of Kansas Medical Center	P2	CCC (48)
FLUDEOXYGLUCOSE Pancreatic Ductal Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (48)
Glipizide Pancreatic Ductal Adenocarcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (48)
Glubran 2 Pancreatic Ductal Adenocarcinoma	Minia University	P2	CCC (48)
HUMAN ADENOVIRUS C SEROTYPE 5 Pancreatic Ductal Adenocarcinoma	Thomas Jefferson University	P2	CCC (48)
Nalirifox Pancreatic Ductal Adenocarcinoma	The University of Texas Health Science Center, Houston	P2	CCC (48)
Odetiglucan Pancreatic Ductal Adenocarcinoma	University of Pennsylvania	P2	CCC (48)

Showing 26 to 50 of 149 assets

PreviousPage 2 of 6Next